Obalon Therapeutics stock soars to lead all gainers on massive volume after ReShape merger deal
Shares of Obalon Therapeutics Inc.
OBLN,
blasted six-fold higher on massive volume in afternoon trading Wednesday, after the weight loss technologies company announced an agreement to merge with weight loss solutions company ReShape Lifesciences Inc.
RSLS,
Obalon’s stock rose 503.4% toward the highest close since JUne 2019, while trading volume soared to 395.4 million shares, compared with the full-day average of about 626,000 shares. The stock was the biggest gainer and most active on major U.S. exchanges on Wednesday. ReShape shares, which currently trade over the counter, rose 155%. When the merger is completed, ReShape shareholders will own 51% of the combined entity, and the company will be renamed Reshape Lifesciences Inc. and will trade on the Nasdaq under the ticker symbol „RSLS.“ „We are excited with this opportunity to add Obalon’s FDA approved Balloon System to ReShape’s line of minimally invasive weight-loss solutions while also expanding our market reach,“ said ReShape Chief Executive Bart Bandy. Obalon’s stock has now rocketed 922.5% over the past three months while ReShape shares have soared 187.3% and the S&P 500
SPX,
has gained 12.0%.
[ad_2]
Source